Disease Overview：Congenital Adrenal Hyperplasia（CAH）
Congenital Adrenal Hyperplasia (CAH) is an autosomal recessive disorder caused by mutations in genes encoding enzymes involved in cortisol biosynthesis—most commonly 21-hydroxylase deficiency (CYP21A2). This leads to impaired glucocorticoid and often mineralocorticoid synthesis, resulting in compensatory adrenocorticotropic hormone (ACTH) elevation, adrenal hyperplasia, and accumulation of precursor steroids. Clinical manifestations vary by enzyme deficiency severity and include salt-wasting crises in infancy, ambiguous genitalia in females (due to prenatal androgen excess), precocious puberty, short stature, infertility, and metabolic complications such as insulin resistance and osteoporosis. Lifelong glucocorticoid replacement—often with hydrocortisone, prednisolone, or dexamethasone—is essential to suppress ACTH-driven androgen overproduction and prevent adrenal insufficiency. Regular endocrine monitoring, growth assessment, bone density evaluation, and psychosocial support are integral to comprehensive management.
China offers distinct advantages for CAH care: leading endocrinology centers—such as Peking Union Medical College Hospital and Shanghai Jiao Tong University Affiliated Ruijin Hospital—feature multidisciplinary teams with deep expertise in rare adrenal disorders, advanced genetic testing (including CYP21A2 sequencing and MLPA), and real-time cortisol/androgen monitoring via LC-MS/MS. Success rates in achieving hormonal normalization, pubertal alignment, and fertility preservation align with international benchmarks. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising clinical rigor or regulatory compliance. As a dedicated medical tourism agency, we facilitate seamless access for international patients—handling hospital referrals, coordinating virtual consultations with CAH specialists, clarifying all-inclusive pricing upfront, arranging visa support, and providing bilingual case management from diagnosis through long-term follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Congenital Adrenal Hyperplasia (CAH)
Non-Surgical / Conservative Management
*Target Criteria:* All CAH patients (classic & non-classic), lifelong glucocorticoid/mineralocorticoid replacement, stress-dose adjustment, growth/puberty monitoring.
- •Baseline Medication Regimen (Monthly):
- Fludrocortisone (oral): ¥80–¥160 ($11–$23) - Salt supplementation (infants): ¥20–¥50 ($3–$7)
- •Essential Monitoring (Per Visit):
- ACTH, testosterone/DHEA-S (pubertal patients): ¥260–¥400 ($37–$57) - Bone age X-ray (annual): ¥180 ($26) - Growth hormone/IGF-1 (if growth failure suspected): ¥220 ($32) - Pelvic/abdominal ultrasound (females with ambiguous genitalia or ovarian cysts): ¥350 ($50)
Surgical / Procedural Interventions
*Eligibility Criteria:* Female infants with Prader III–V virilization requiring genitoplasty; adults with adrenal myelolipoma >6 cm or symptomatic adrenal masses confirmed as CAH-related.
- •Adrenalectomy (Unilateral, Laparoscopic):
- Surgery + anesthesia + 3-day hospital stay: ¥28,000–¥42,000 ($4,000–$6,000)
- •Feminizing Genitoplasty (Infancy/Childhood):
- Clitoroplasty + vaginoplasty + labioplasty (single-stage): ¥15,000–¥22,000 ($2,150–$3,150) - Post-op urodynamic study (if voiding dysfunction): ¥680 ($97)
Special / Complex Condition Management
- •Adrenal Crisis Hospitalization (ICU admission, IV hydrocortisone, fluid resuscitation): ¥12,000–¥18,000/day ($1,720–$2,570/day)
- •Late-diagnosed Adult CAH with Infertility:
- Assisted reproductive therapy (ovarian stimulation + IUI): ¥8,500 ($1,215)
- •Cushingoid Complications (e.g., severe obesity, osteoporosis):
- Vertebral fracture assessment (MRI lumbar spine): ¥1,400 ($200)
Quick Selection Guide
- •Newborns with Classic CAH: Immediate hydrocortisone + fludrocortisone + salt; genitoplasty only if Prader ≥III — *optimal: Tier-1 meds + surgery at 3–6 months*.
- •Children (3–12 yrs) with Growth Delay: Add growth hormone trial (¥3,200/month; $460) only if IGF-1 <−2 SDS and bone age delay >2 years.
- •Adults with Non-Classic CAH & Fertility Concerns: Low-dose glucocorticoids + timed intercourse; avoid surgery unless adrenal mass >6 cm.
- •Budget-Constrained Patients (<$500/month): Prioritize generic hydrocortisone + fludrocortisone + annual 17-OHP/electrolytes; defer imaging unless symptomatic.
- •Patients with Comorbid Hypertension or Diabetes: Add renal artery Doppler (¥420; $60) and HbA1c (¥65; $9) to baseline labs.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Congenital Adrenal Hyperplasia Medical Vacation Packages
Curated transparent all-inclusive packages combining Congenital Adrenal Hyperplasia treatment with China top medical destinations:
